Short answer
Elevance Health (ELV) filed its Q1 2026 10-Q quarterly report on Apr 22, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $50.2B (up 2.6% year over year) with net income of $1.8B.
Q1 2026 key financials · XBRL
- Revenue
- $50.2B
- +2.6% YoY
- Net income
- $1.8B
- −19.2% YoY
- Operating margin
- 4.2%
- EPS (diluted)
- $8.00
- −16.8% YoY
Source: XBRL data from the Elevance Health (ELV) Q1 2026 10-Q on SEC EDGAR. USD.
Elevance Health Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Medical membership 45.4 million as of March 31, 2026
- Four reportable segments: Health Benefits, CarelonRx, Carelon Services, Corporate & Other
- Quarterly revenue, profitability margins, cash flow, and capital deployment not provided
Risk Factors
- Risk Factors section not provided; supplied text covers Items 2–6
- No newly added risk factor identifiable from the provided excerpt
- No materially updated regulatory, legal, compliance, operational, or competitive risk disclosed in the provided excerpt
- Share repurchase authorization: $5,571 million remaining at March 31, 2026
- Repurchase activity: 3,688,427 shares acquired for aggregate cost of $1,124 million
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Elevance Health quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.